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Significance of the Study
• This novel study demonstrates that an elevated gamma gap is associated with worse cognition, and that 
among subjects with an elevated gamma gap, those who are physically active have greater cognition.
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Abstract
Objective: An elevated gamma gap is indicative of high se-
rum concentrations of globulin proteins, some of which elic-
it acute inflammatory responses. An impaired cognitive 
function has been linked to central and peripheral inflamma-
tion, while exercise is associated with protective, anti-inflam-
matory benefits. In this study, we evaluated whether the 
gamma gap is associated with cognitive function among 
older adults and whether physical activity is favorably associ-
ated with cognitive function among those with an elevated 
gamma gap. Materials and Methods: Data from the 1999–
2002 National Health and Nutrition Examination Survey 
(NHANES) were used to identify 2,352 older adults aged be-
tween 60 and 85 years. The gamma gap was evaluated by 
subtracting albumin from total protein, i.e., gamma gap = 
total protein (g/dL) – albumin (g/dL). Those at or above 3.1 
g/dL (31.0 g/L) were considered to have an elevated gamma 
gap. The Digit Symbol Substitution Test (DSST) was used to 
assess cognitive function tasks of pairing and free recall 
among participants. Participants were asked open-ended 
questions about participation in leisure-time physical activ-
ity over the previous 30 days. Results: Those with an elevat-
ed gamma gap (DSST, 44.8) had a lower cognitive function 
score when compared to those without an elevated gamma 
gap (DSST, 50.1) (p < 0.001). After adjustments, and among 
those with an elevated gamma gap, those meeting the mod-
erate-to-vigorous intensity physical activity (MVPA) guide-
lines (vs. not meeting them) had a DSST score of 6.42 units 
higher (β = 6.42, 95% CI 3.85–8.99, p < 0.001). Conclusion: In 
this national sample of older adults, the gamma gap was as-
sociated with cognitive function, and among those with an 
elevated gamma gap, meeting the physical activity guide-
lines was associated with a higher cognitive function. Rele-
vant clinical implications are discussed, as the gamma gap 
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may be predictive of the risk for early mortality and reduced 
quality of life. Experimental work is needed to investigate 
whether physical activity training programs are effective in 
reducing an elevated gamma gap and preserving optimal 
cognitive functioning among at-risk individuals.
© 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
The gamma gap is known as the globulin fraction, an 
indicator for cardiovascular risk factors [1] associated 
with morbidity and mortality [2]. Globulins are dissolved 
plasma proteins, clinically measurable in plasma serum 
concentrations. The gamma gap is calculated by subtract-
ing albumin (g/dL) from total plasma protein concentra-
tion (g/dL) [3]. The globulin fraction is divided into four 
separate fractions, a1, a2, β, and ɣ, which are classified ac-
cording to their migratory sequence during electrophore-
sis. An increase in plasma globulin proteins results in an 
elevated globulin fraction, usually due to changes in im-
munoglobulin content [3]. β and ɣ globulins may be high-
er in chronic disease states, such as diabetes or heart dis-
ease. These globulin proteins are significant determinants 
of acute inflammatory responses [4]. In addition, patho-
genic states characterized by infection, plasma cell malig-
nancy, as well as varied autoimmune disorders that often 
exhibit elevated immunoglobulin and albumin-indepen-
dent protein content may all be predictive of an increased 
gamma gap [5]. An elevated gamma gap has been associ-
ated with all-cause mortality in nonclinical populations, 
with inflammation compromising sufficient albumin 
production, and subsequently promoting an increased 
serum C-reactive protein level, a likely mechanism for 
significant health complications and/or early mortality 
[5]. An impaired cognitive function has been linked to 
central and peripheral inflammation [6]. The globulin 
proteins, characteristic of a gamma gap elevation, are 
positively associated with inflammation, contributing to 
the likelihood for those with an elevated gamma gap to 
be at a higher risk for cognitive dysfunction. Previous 
work has further detailed and described this gamma gap 
[2, 7, 8].
To our knowledge, no study has specifically evaluated 
the effect of an elevated gamma gap on cognitive function 
among the elderly. Based on the current understanding of 
the gamma gap, and its role in inflammatory disease pro-
cesses [4, 9], it is conceivable that those with an elevated 
gamma gap would have a diminished cognitive function, 
and that physical activity may offer a protective effect 
among those with an elevated gamma gap. Exercise is as-
sociated with numerous health outcomes [10] and has 
been shown to elicit protective, anti-inflammatory ben-
efits [11, 12], which could potentially have a moderating 
effect on inflammatory-based cognitive dysfunction in 
individuals with an elevated gamma gap. Thus, the pur-
pose of this study was to (1) determine whether the gam-
ma gap is associated with cognitive function, and (2) eval-
uate whether meeting physical activity guidelines (150 
min of moderate-to-vigorous intensity physical activity 
[MVPA] per week) [13] is favorably associated with cog-
nitive function among older adults with an elevated gam-
ma gap. Such an investigation will have important public 
health implications in identifying the potential putative 
role that physical activity may play in influencing cogni-
tion among older adults with an elevated gamma gap.
Methods
Study Design 
Data from the 1999–2002 National Health and Nutrition Ex-
amination Survey (NHANES) were used. Study procedures were 
approved by the National Center for Health Statistics ethics review 
board, with informed consent obtained prior to data collection. 
The NHANES is an ongoing survey conducted by the Centers 
for Disease Control and Prevention that uses a representative sam-
ple of noninstitutionalized United States civilians selected by a 
complex, stratified, and clustered probability design. The multi-
stage design consists of 4 stages, including the identification of 
counties, segments (city blocks), random selection of households 
within the segments, and random selection of individuals within 
the households. Further information on NHANES methodology 
and data collection is available on the NHANES website (http://
www.cdc.gov/nchs/nhanes.htm). 
Gamma Gap
Using the Hitachi Model 704 multichannel analyzer, the gam-
ma gap was evaluated by subtracting albumin (bromocresol purple 
reagent using the Beckman Synchron LX20) from total protein 
(colorimetric assay using the Beckman Synchron LX20), i.e., gam-
ma gap = total protein (g/dL) – albumin (g/dL). As in previous 
reports [2, 7, 8], those at or above 3.1 g/dL (31.0 g/L) were consid-
ered to have an elevated gamma gap. 
Cognitive Function
The Digit Symbol Substitution Test (DSST) was used to assess 
cognitive function [14–16], which was administered to adults over 
60 years of age. The DSST, a component of the Wechsler Adult 
Intelligence Test and a test of visuospatial and motor speed-of-
processing, has a considerable executive function component and 
is frequently used as a sensitive measure of frontal lobe executive 
functions [17]. The DSST was used to assess participant cognitive 
function tasks of pairing (each digit, 1–9, has a symbol it is associ-
ated with) and information processing. Participants were asked to 
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draw as many symbols as possible that were paired with numbers 
within 2 min. Following the standard norm-referenced scoring 
method, one point is given for each correctly drawn and matched 
symbol, and one point is subtracted for each incorrectly drawn and 
matched symbol, with a maximum score of 133. 
Physical Activity
As described elsewhere [18], participants were asked open-
ended questions about participation in leisure-time physical activ-
ity over the previous 30 days. Data was coded into 48 activities, 
including 16 sports-related activities, 14 exercise-related activities, 
and 18 recreational-related activities. For each activity, Metabolic 
Equivalent of Task (MET)-min-month was calculated by multiply-
ing the number of days, by the mean duration, by the respective 
MET level (MET-min-month = days • duration • MET level). Those 
at or above 2,000 MET-min-month (equivalent to 150 min/week) 
were defined as physically active.
Covariates
For all models, covariates included age, gender, race/ethnicity 
(Mexican American, other Hispanic, non-Hispanic white, non-
Hispanic black, other), self-reported smoking (yes/no), energy in-
take (kcal, continuous), physician-diagnosed hypertension (yes/
no), weight status (overweight/obese [measured body mass index 
or higher] vs. normal weight), and glycated hemoglobin (%, con-
tinuous). 
Participants were classified as smokers if they self-reported 
smoking every day or some days; otherwise, they were classified as 
nonsmokers. Previous research demonstrates evidence of validity 
for self-reported smoking assessment [19]. Energy intake (kcal) 
was assessed from the mobile examination center interview, per 
NHANES guidelines, and the follow-up telephone interview. The 
average of these values was used. If data were missing from the 
telephone interview, only energy intake obtained from the mobile 
examination center was used. Glycated hemoglobin was deter-
mined from the Primus instrument, which is a fully automated 
glycohemoglobin analyzer that utilizes the principle of boronate 
affinity high-performance liquid chromatography. 
Analysis
All statistical analyses, computed in Stata (v. 12), accounted for 
the complex survey design employed in NHANES. An adjusted 
Wald test was used to examine statistical differences for continu-
ous variables among those with and without an elevated gamma 
gap (Table 1). A design-based likelihood ratio test was used for 
categorical variables. A weighted multivariable linear regression 
model was used to examine the association of meeting physical 
activity guidelines (≥2,000 MET-min-month) and cognitive func-
tion (outcome variable). Statistical significance was established as 
an alpha < 0.05. 
Results
The analyzed sample included 2,352 older adults (60–
85 years). Among these, 1,121 had an elevated gamma gap 
(3.1–6.3 g/dL) and 1,230 did not (2.0–3.0 g/dL). Charac-
teristics of the study variables, stratified by the gamma 
gap status, are displayed in Table 1. Those with an elevat-
ed gamma gap, compared to those without, had a worse 
DSST score (44.8 vs. 50.1). This was even further accentu-
ated among those with a more severe gamma gap. For 
example, when comparing those with a gamma gap level 
of > 4.0 g/dL to those with a level of < 3.0 g/dL, respective-
ly, the mean DSST scores were 35.7 versus 50.1. As shown 
in Table 1, other differences emerged when comparing 
those with and without an elevated gamma gap. Those 
with an elevated gamma gap were older, had a lower en-
ergy intake, had a higher A1C level, were more likely to 
be hypertensive, were more likely to be a minority, were 
more likely to be female, and were less likely to meet the 
MVPA guidelines. Notably, there were no differences in 
Table 1. Weighted characteristics of the study variables among a national sample of adults with and without an elevated gamma gap ac-
cording to 1999–2002 NHANES data
Variables Normal gamma gap (n = 1,230) Elevated gamma gap (n = 1,121) p value
Mean DSST 50.1 (48.5–51.7) 44.8 (42.9–46.0) <0.001
Mean age, years 69.5 (68.94–70.13) 70.4 (69.58–71.27) 0.03
Mean energy intake, kcal 1,862.7 (1,809.59–1,915.84) 1,701.2 (1,642.94–1,759.5) <0.001
Mean A1C level, % 5.6 (5.61–5.75) 5.9 (5.85–6.0) <0.001
Mean hypertension, % 46.0 (0.43–0.50) 53.0 (0.49–0.51) 0.01
White race, % 89.7 (0.87–0.92) 75.0 (0.69–0.81) <0.001
Female gender, % 52.0 (0.50–0.55) 59.0 (0.56–0.61) 0.002
Current smoker, % 12.0 (0.10–0.13) 14.0 (0.10–0.13) 0.22
Meeting MVPA guidelines, % 42.0 (0.36–0.47) 31.0 (0.26–0.35) <0.001
Overweight/obese, % 69.0 (0.64–0.73) 72.0 (0.68–0.76) 0.18
Values are point estimates with 95% CI in parentheses. A1C, glycated hemoglobin; DSST, Digit Symbol Substitution Test; MVPA, 
moderate-to-vigorous physical activity.
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smoking status and weight status among those with and 
without an elevated gamma gap.
Table 2 displays the weighted multivariable linear re-
gression results among those with and without an elevat-
ed gamma gap. Those meeting the MVPA guidelines and 
not having an elevated gamma gap had a DSST score of 
5.4 units higher than their counterparts not meeting the 
MVPA threshold (β = 5.40, 95% CI 3.10–7.71, p < 0.001). 
Those meeting the MVPA guidelines and having an ele-
vated gamma gap had a DSST score 6.42 units higher than 
their counterparts not meeting the MVPA threshold (β = 
6.42, 95% CI 3.85–8.98, p < 0.001). 
Discussion
The gamma gap is an important clinical measure, as it 
is useful in the differential diagnosis of chronic diseases 
associated with physical inactivity and inflammation [7]. 
The deleterious inflammatory consequences of an elevat-
ed gamma gap may potentially influence both physical 
and cognitive parameters. Previous studies have exam-
ined the effects of an elevated gamma gap on cognitive 
function. Klimkowicz et al. [20] found that increased se-
rum γ-globulin concentrations are an independent he-
matological marker of cognitive decline among elderly, 
prestroke dementia patients. Moreover, expansion of the 
gamma gap may be a function of senescence. Studies on 
mice and nonhuman primates suggest that autoimmu-
nity may be proliferated in old age, contributing to pro-
gressive cognitive dysfunction via neural degeneration 
[21]. In this context, autoimmune responses are stimu-
lated by globulin-mediated antibody formation [22]. 
These antibodies appear to have an increased affinity to 
neuronal binding sites within the aging brain [23]. This 
evidence is a cause for concern, as health status, quality of 
life, and all-cause mortality may be significantly dimin-
ished by the risks associated with an elevated gamma gap.
To our knowledge, no study has previously evaluated 
the direct association between the gamma gap and cogni-
tive function and whether physical activity is favorably 
associated with cognitive function among those with an 
elevated gamma gap. However, many studies have exam-
ined potential relationships between physical activity and 
cognitive function [24–28]. Hamer and Chida [26] iden-
tified 16 prospective studies that investigated the pro-
posed inverse association between physical activity and 
cognitive decline. Various analyses point to regular phys-
ical activity as a crucial mediator in controlling blood 
pressure, cholesterol, and the accumulation of proinflam-
matory cytokines [29], which may impede neural signal-
ing pathways [26, 27]. Therefore, our present study adds 
to the research and supplies a clearly defined explanation 
of physical activity frequency and duration, which has 
Table 2. Association between meeting physical activity guidelines and cognitive function among those with and without an elevated 
gamma gap
Normal gamma gap (n = 1,230) Elevated gamma gap (n = 1,121)
β 95% CI p value β 95% CI p value
Meeting MVPA guidelines vs. not 5.40 3.10, 7.71 <0.001 6.42 3.85, 8.98 <0.001
Covariates
Age, 1-year increase –1.0 –1.11, –0.9 <0.001 –0.78 –0.91, –0.64 <0.001
Female vs. male 5.27 2.71, 7.84 <0.001 5.05 2.11, 8.00 0.001
Race/ethnicity
Mexican American vs. white –14.5 –18.1, –10.9 <0.001 –15.2 –19.0, –11.5 <0.001
African American vs. white –16.4 –20.8, –12.0 <0.001 –14.4 –17.3, –11.6 <0.001
Other vs. white –10.2 –16.5, –3.9 0.003 –12.4 –18.2, –6.7 <0.001
Nonsmoker vs. smoker 1.3 –1.7, 4.4 0.37 5.0 1.3, 8.6 0.009
Energy intake, 1-kcal increase 0.001 0.00007, 0.003 0.04 0.001 –0.0005, 0.003 0.14
A1C level, 1% increase –2.2 –3.2, –1.3 <0.001 –1.3 –2.3, –0.43 0.006
Overweight/obese vs. not 0.29 –2.7, 3.3 0.84 0.16 –3.0, 3.3 0.91
Hypertension vs. not –2.3 –4.2, –0.5 0.01 –2.8 –5.9, 0.16 0.06
Two multivariable linear regression models were computed: one for those with a normal gamma gap (<3.1 g/dL) and one for those 
with an elevated gamma gap (≥3.1 g/dL). In both models, covariates included age, gender, race/ethnicity, smoking status, energy intake, 
A1C level, weight status, and hypertension status. MVPA, moderate-to-vigorous physical activity. 
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been lacking in previous experiments. We found that ad-
equate physical activity levels may attenuate negative 
neurocognitive outcomes among older individuals with 
an elevated gamma gap. Indeed, our results demonstrate 
that those with an elevated gamma gap had worse cogni-
tive function when compared to those with a normal 
gamma gap. Furthermore, those with an elevated gamma 
gap who met physical activity guidelines had greater cog-
nitive function when compared to their less active coun-
terparts. 
The need for tailored physical activity programs for 
older adults is of critical importance. Modifiable risk fac-
tors for morbidity and mortality increase with age and are 
manifest among older populations [30, 31]. Moreover, 
the globulin fraction has been shown to increase in old 
age [32], while optimal cognitive function may be im-
paired [33]. Our results are suggestive of a possible in-
verse relationship between age-associated increases in the 
gamma gap and insufficient physical activity levels. Fur-
thermore, our findings demonstrate a positive associa-
tion between physical activity and cognitive function 
among those with an elevated gamma gap. We have also 
demonstrated that older age, race/ethnicity minority sta-
tus, hypertension, and A1C level increase were signifi-
cantly associated with lower cognitive function among 
individuals with a normal gamma gap, as well as those 
with an elevated gamma gap. Female gender and in-
creased energy intake were significantly associated with 
improved cognitive functioning for those with a normal 
gamma gap, while female gender and nonsmoking status 
were significantly related to improved cognition among 
participants with an elevated gamma gap. Collectively, 
these results are of clinical importance for medical profes-
sionals and exercise physiologists aiming to improve 
physical and mental outcomes for the elderly. 
This study is not without limitations, which include 
the subjective assessment of physical activity and cross-
sectional design. In addition, this study utilized partici-
pant responses to a single cognitive task (DSST), which 
may not necessarily be generalizable to other cognitive 
domains. Cognitive impairment associated with an ele-
vated gamma gap in older adults may also limit the valid-
ity of self-report data although we do not believe that a 
mild level of cognitive impairment associated with aging 
would affect the ability of participants to accurately re-
spond to interview questions. Nevertheless, there is a pos-
sibility that this level of cognitive dysfunction may atten-
uate self-report accuracy for some aging individuals eval-
uated for this study. Notable strengths include the 
national sample and study novelty. Thus, future prospec-
tive work on this topic using an objective measure of 
physical activity is warranted. 
Conclusions
This study has important clinical implications, as the 
gamma gap may be predictive of the risk for early moral-
ity and reduced quality of life. Future work is also needed 
to examine the extent to which the observed differences 
in cognition in the present sample are clinically meaning-
ful differences. Clinicians and health professionals may 
look at prescribing safe and tailored physical activity par-
ticipation as a potential strategy to offset or mitigate the 
deleterious effects of gamma gap inflation during older 
age. However, experimental work is needed to investigate 
whether physical activity training programs are effica-
cious in meaningfully reducing an elevated gamma gap 
and preserving optimal cognitive functioning among at-
risk individuals.
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